BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16556617)

  • 1. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
    Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
    Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
    Kim M; Kim JH; Kim JH; Kim DH; Yu YS
    Korean J Ophthalmol; 2010 Feb; 24(1):35-9. PubMed ID: 20157412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.
    Balla MM; Vemuganti GK; Kannabiran C; Honavar SG; Murthy R
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1506-14. PubMed ID: 19029022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
    Youssef NS; Said AM
    Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell characteristics in retinoblastoma.
    Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
    Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas ligand in retinoblastoma.
    Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
    Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
    Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress of cancer stem cells of solid tumor].
    Ni XG; Zhao P
    Ai Zheng; 2006 Jun; 25(6):775-8. PubMed ID: 16764780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
    Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
    Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells.
    Huang L; Lu Q; Han Y; Li Z; Zhang Z; Li X
    Diagn Pathol; 2012 Dec; 7():180. PubMed ID: 23244569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.